1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by NIH (National Institute of Mental Health, National Institute on Minority Health and Health Disparities). This NIH SBIR Omnibus Solicitation invites investigator-initiated applications from small businesses for early-stage research and development projects.
The program aims to stimulate technological innovation, meet federal R&D needs, and increase private sector commercialization of innovations, with a focus on biomedical technology and health-related research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small business concerns. Eligibility criteria include being a for-profit company, and meeting specific requirements for primary employment of the principal investigator. Confirm the full requirements on the funder's own website before applying.
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is funded by NIH (National Institute of Mental Health, National Institute on Minority Health and Health Disparities). Verify program details on the funder's own website before applying.
Start from the grants-portal listing linked on this page, then confirm the submission instructions on the funder's own website — the listing is a third-party summary, not the funder's RFP.
Past winners and funding trends for this program
The John Lewis NIMHD Research Endowment Program is forecast to reopen as RFA-MD-28-001, with $12 million for six awards at a $2 million ceiling. Every slot is currently held. Here are 25 years of award data, the eligibility test, and the regulation that freezes the money for two decades.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article